Cheung, Eric C.
Vousden, Karen H. http://orcid.org/0000-0002-7365-1766
Article History
Accepted: 3 December 2021
First Online: 31 January 2022
Competing interests
: K.H.V. is on the Board of Directors and a shareholder of Bristol Myers Squibb, a shareholder of Illumina, Inc., on the Science Advisory Board (with stock or stock options) of PMV Pharma, RAZE Therapeutics, Kovina Therapeutics and Volastra Therapeutics, and a co-founder and consultant of Faeth Therapeutics. She has been in receipt of research funding from Astex Pharmaceuticals and AstraZeneca, and contributed to CRUK Cancer Research Technology filing of patent application WO/2017/144877. E.C.C. declares no competing interests.